A Recombinant Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Against Various Hematologic Malignancies Shows Selective Inhibition of Colony Formation From Long-Term Culture-Initiating Cells (LTC-ICs) In Primary Leukemia SamplesVarghese Palath, Christopher Bebbington, Nenad Tomašević et al.|Blood|2010Cited by 6
A Recombinant Human Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Shows Selective Cytotoxicity against Myeloid Leukemia Cells and CD123-Positive Leukemic Stem Cells.Varghese Palath, Christopher Bebbington, Rohini Vekhande et al.|Blood|2009Cited by 3